New existing drug portfolio found to remove virus from new coronary pneumonia patients

In a small study conducted in France, a specific combination of existing drugs showed its ability to eliminate the new coronavirus,media reported. Doctors have provided a combination of antimalarial drugs, the antimalarial drug hydroxychloroquine, and the antibiotic azithromycin, which has been diagnosed with new coronary pneumonia. 该项试验结果已发表在《International Journal of Antimicrobial Agents》上。

New existing drug portfolio found to remove virus from new coronary pneumonia patients

It is reported that a total of 30 patients with new coronary pneumonia participated in the trial. These people were divided into three groups. Of these, 10 took only antimalarial drugs, while 10 of the other group took hydroxychloroquine and antibiotics at the same time, and the third group of 10 were in the control group without any treatment.

It is worth noting that while antimalarial drugs have been shown to significantly shorten a patient’s infection time, the therapeutic results from the combination of the two drugs are truly alarming. In fact, on the fifth day of treatment, all patients treated with a combination of drugs tested negative for the active virus.

The test does show great therapeutic prospect, but because it is too small, it is not really effective.

For now, the most important thing people can do is to stay away from society, follow the advice of health officials, and stay at home to help slow the spread of the epidemic.